It is a trading private limited company based in South Delhi, Delhi, India, established in 2011.
2011 | South Delhi, Delhi, India | ActiveSyngene Bioimaging Private Limited, a active private limited company, was established on 28 March 2011 in South Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U33120DL2011PTC216598. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Mukesh Kumar Shukla (Additional Director), Shashank Kumar (Director), Poonam Bakhru (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-6/1 Ff, Kh. No. 455, Indira Enclave, Neb Sarai, South Delhi, Delhi, 110068.
U33120DL2011PTC216598
216598
28 March 2011
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Syngene Bioimaging Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Kumar Shukla | Additional Director | 08 May 2024 | Current |
| Shashank Kumar | Director | 08 May 2024 | Current |
| Poonam Bakhru | Director | 28 Mar 2011 | Current |
| Vijay Bakhru | Director | 28 Mar 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Syngene Bioimaging Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Syngene Bioimaging had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Syngene Bioimaging, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Syngene Bioimaging, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syngene Bioimaging's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Syngene Bioimaging Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Mukesh Kumar Shukla was appointed as a Additional Director was appointed as a Additional Director on 08 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Shashank Kumar was appointed as a Director was appointed as a Director on 08 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Progress on Syngene Bioimaging Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Poonam Bakhru was appointed as a Director was appointed as a Director on 28 Mar 2011 & has been associated with this company since 14 years 8 months . was documented.
The activity Vijay Bakhru was appointed as a Director was appointed as a Director on 28 Mar 2011 & has been associated with this company since 14 years 8 months . was completed.
The CIN of Syngene Bioimaging Private Limited is U33120DL2011PTC216598.
Syngene Bioimaging Private Limited is headquartered at A-6/1 Ff, Kh. No. 455, Indira Enclave, Neb Sarai, South Delhi, Delhi, 110068.
Syngene Bioimaging Private Limited was incorporated on 28 March 2011.
The current directors of Syngene Bioimaging Private Limited are
The primary industry of Syngene Bioimaging Private Limited is Trade.
Syngene Bioimaging Private Limited is unlisted.
The authorized capital of Syngene Bioimaging Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Syngene Bioimaging Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX